Trial intelligence / Profile preview

Early Fraxel Laser for Acne Scars Post-Isotretinoin

NCT03514771Completed

Start
Jan 2016
Primary completion
Mar 2017
01

Overview

Randomised, single-blind trial. Primary endpoint: Adverse events associated with early non-ablative fractional laser resurfacing at 4 months. Started Jan 2016; status: completed.

Beyond the preview

Go deeper on NCT03514771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03514771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call